Stocks and InvestingStocks and Investing
Mon, August 23, 2021
Fri, August 20, 2021
Thu, August 19, 2021
Wed, August 18, 2021
Tue, August 17, 2021

Nathan Weinstein Maintained (ATAI) at Strong Buy with Increased Target to $27 on, Aug 17th, 2021


Published on 2024-10-27 17:40:49 - WOPRAI, Nathan Weinstein
  Print publication without navigation


Nathan Weinstein of Aegis Capital, Maintained "Atai Life Sciences N.V." (ATAI) at Strong Buy with Increased Target from $26 to $27 on, Aug 17th, 2021.

Nathan has made no other calls on ATAI in the last 4 months.



There are 7 other peers that have a rating on ATAI. Out of the 7 peers that are also analyzing ATAI, 1 agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $19 on, Tuesday, July 13th, 2021


These are the ratings of the 6 analyists that currently disagree with Nathan


  • Leonildo Delgado of "Baader Helvea" Initiated at Strong Buy and Held Target at $21 on, Wednesday, July 14th, 2021
  • Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $26 on, Tuesday, July 13th, 2021
  • Ritu Baral of "Cowen & Co." Initiated at Buy on, Tuesday, July 13th, 2021
  • Charles Duncan of "Cantor Fitzgerald" Initiated at Buy and Held Target at $45 on, Tuesday, July 13th, 2021
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $35 on, Tuesday, July 13th, 2021
  • Judah Frommer of "Credit Suisse" Initiated at Buy and Held Target at $25 on, Tuesday, July 13th, 2021